Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency that is widely associated with type 1 and, less commonly, type 2 diabetes. However, a lesser-known but equally dangerous scenario occurs when non-diabetic individuals with pancreatic disorders develop DKA. This can happen when the pancreas, damaged by conditions such as acute pancreatitis, chronic pancreatitis, pancreatic tumors, or pancreatic surgery, fails to produce sufficient insulin. Without adequate insulin, the body cannot use glucose for energy and instead breaks down fatty acids at an accelerated rate, generating ketone bodies that acidify the blood. Recognizing the symptoms of DKA in this population is critical for prompt diagnosis and treatment, especially because the underlying pancreatic disorder may mask the warning signs.

Understanding DKA in Non-Diabetic Patients

DKA is characterized by the triad of hyperglycemia (elevated blood glucose), ketosis (elevated ketone bodies in blood or urine), and metabolic acidosis (low blood pH). In diabetic patients, the primary cause is absolute or relative insulin deficiency. In non-diabetic individuals, the mechanism is similar but triggered by pancreatic pathology that impairs beta-cell function.

The pancreas houses the islets of Langerhans, which contain beta cells that produce insulin. When the pancreas is inflamed (pancreatitis), infiltrated by tumors, or surgically removed or damaged, beta-cell mass and function can decline dramatically. This leads to a state of insulinopenia—insufficient insulin to suppress lipolysis and ketogenesis. Even patients with no prior history of diabetes can develop DKA if the pancreas is sufficiently compromised.

Several studies have documented euglycemic DKA (blood glucose less than 250 mg/dL) in non-diabetic patients with pancreatic disorders, making the condition even more difficult to spot. This variant may present with near-normal sugar levels but still feature significant ketosis and acidosis. Therefore, relying solely on glucose readings can delay recognition.

Key Symptoms to Watch For

The symptoms of DKA in non-diabetic individuals with pancreatic disorders overlap with those of classic DKA but may be obscured by the primary pancreatic illness. Below is a detailed breakdown of the most important signs.

High Blood Sugar Levels

Although euglycemic DKA exists, most patients will have elevated blood glucose. In non-diabetic individuals, random glucose levels above 200 mg/dL or fasting levels above 126 mg/dL warrant investigation. However, in the context of acute pancreatitis, stress hyperglycemia is common, so a single high reading does not confirm DKA. Serial glucose and ketone monitoring is recommended.

Frequent Urination and Intense Thirst

Hyperglycemia causes osmotic diuresis—glucose spills into the urine, drawing water with it. This leads to polyuria (frequent urination) and compensatory polydipsia (excessive thirst). Patients may report waking multiple times at night to urinate or drinking large volumes without satisfaction. Dehydration can rapidly progress, especially in the setting of vomiting or reduced oral intake due to abdominal pain.

Nausea, Vomiting, and Abdominal Pain

Nausea and vomiting are classic DKA symptoms but are also hallmarks of pancreatitis. This overlap makes it challenging to distinguish DKA from a pancreatic flare. Patients may describe epigastric pain that radiates to the back, worsened by eating or lying flat. In DKA, the pain is often accompanied by tenderness but may also be referred from gastric stasis and acidosis. Persistent vomiting despite standard antiemetic therapy should raise suspicion for ketoacidosis.

Rapid Breathing (Kussmaul Respirations)

As the blood becomes acidic, the respiratory center in the brainstem triggers deep, rapid breaths to blow off carbon dioxide and compensate for metabolic acidosis. This breathing pattern is called Kussmaul respirations. It may be misinterpreted as anxiety or a pulmonary issue, but in a patient with a pancreatic disorder, it is a red flag for DKA. The respiratory rate can exceed 30 breaths per minute, and the breaths are often deep and sighing.

Confusion, Fatigue, and Neurological Changes

Acidosis and hyperosmolarity impair brain function. Early symptoms include headache, drowsiness, and difficulty concentrating. As acidosis worsens, patients may become confused, lethargic, or comatose. In older adults or those with preexisting cognitive impairment, these changes may be subtle. Family members may notice uncharacteristic behavior or reduced responsiveness. Seizures can occur in severe cases.

Fruity-Smelling Breath

Acetone, a ketone body, is volatile and is exhaled through the lungs. It gives the breath a distinct sweet, fruity odor, often described as similar to nail polish remover or pear drops. This is a highly specific sign of ketosis. However, it may be masked by the smell of vomitus in patients who are actively vomiting. Healthcare providers and caregivers should be alert to this clue, especially if the patient cannot articulate symptoms.

Other Signs

Additional symptoms include generalized weakness, muscle cramps, tachycardia, dry skin and mucous membranes (due to dehydration), and a flushed appearance. Hypotension may develop from volume depletion. Patients may also exhibit a decreased level of consciousness that progresses to coma if untreated. In children with pancreatic disorders, DKA can present with rapid onset and should not be dismissed because of young age or absence of diabetes.

Differential Diagnosis: DKA vs. Other Pancreatic Complications

Non-diabetic patients with pancreatic disorders frequently present with abdominal pain, nausea, and vomiting. It is essential to differentiate DKA from other complications such as infected pancreatic necrosis, pseudocyst formation, or acute pancreatitis exacerbation. The presence of hyperglycemia, ketonuria, and metabolic acidosis (low serum bicarbonate and low pH on arterial blood gas) points toward DKA. Elevated lipase and amylase indicate pancreatic inflammation, but these can coexist. A serum beta-hydroxybutyrate level greater than 3 mmol/L confirms ketosis. In cases of euglycemic DKA, blood glucose may be below 200 mg/dL, so ketone testing is mandatory.

Other conditions that mimic DKA include alcoholic ketoacidosis (usually with a history of heavy alcohol use and normal to low glucose), starvation ketosis (mild ketones, no acidosis), and lactic acidosis from sepsis or hypoperfusion. Careful history and laboratory evaluation help clarify the cause.

When to Seek Emergency Medical Help

The onset of DKA in non-diabetic individuals with pancreatic disorders can be rapid, sometimes within hours. Any patient with a known pancreatic condition who develops rapid breathing, confusion or drowsiness, fruity-smelling breath, or severe abdominal pain with vomiting requires immediate emergency care. Do not wait for a diabetes diagnosis. In the emergency department, the team will check blood glucose, serum ketones, electrolytes, and blood gases. Early administration of intravenous fluids, insulin, and electrolyte replacement (especially potassium) is lifesaving.

Delays in treatment can lead to severe metabolic acidosis, cardiac arrhythmias (due to potassium shifts), acute kidney injury, cerebral edema (more common in children), and death. Mortality rates for DKA are less than 5% in experienced centers but rise significantly with delayed recognition and in patients with comorbidities such as ongoing pancreatitis or sepsis.

Preventive Measures and Monitoring

For individuals with pancreatic disorders—whether from acute or recurrent pancreatitis, chronic pancreatitis, autoimmune pancreatitis, or pancreatic tumors—prevention of DKA centers on early detection of insulin deficiency and proactive monitoring. Below are key strategies.

Regular Blood Glucose and Ketone Monitoring

Patients with significant pancreatic damage should consider home glucose monitoring, especially during episodes of acute illness, fasting, or after procedures. If blood glucose exceeds 250 mg/dL, urine or blood ketones should be tested. For those with a history of pancreatic surgery (e.g., partial pancreatectomy), periodic hemoglobin A1c and fasting glucose assessments can identify developing prediabetes or diabetes. Outpatient continuous glucose monitors (CGMs) can provide real-time data and alert for hyperglycemia.

Hydration and Sick-Day Management

Dehydration accelerates hyperglycemia and ketosis. Patients should be counseled to maintain adequate fluid intake, especially during febrile illnesses or when vomiting. If oral intake is not possible, they should seek medical attention for intravenous fluids. A sick-day plan should include instructions to check glucose every 4 hours and to stop any medications that may affect insulin secretion (such as sulfonylureas if they have been started for secondary diabetes). Ironically, some pancreatic patients may be on glucocorticoids (for autoimmune pancreatitis), which can further elevate blood sugar; these patients require closer monitoring.

Education and Action Plan

Both patients and their families must be educated about the signs of DKA. Printed materials or digital resources from organizations such as the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) can be helpful. The plan should specify when to measure ketones, what numbers are concerning (e.g., blood ketones > 1.5 mmol/L), and when to call 911. For patients with pancreatic tumors, especially those undergoing chemotherapy or radiation, the risk of DKA may be transiently increased and should be discussed with the oncology team.

Medical Follow-Up and Pancreatic Function Testing

Regular visits with a gastroenterologist or endocrinologist can help monitor exocrine and endocrine pancreatic function. After an episode of acute pancreatitis, the risk of developing diabetes is elevated, and a 75-gram oral glucose tolerance test may be indicated. For those with chronic pancreatitis, fecal elastase testing can identify exocrine insufficiency, which often coexists with endocrine decline. Managing the underlying pancreatic disorder—through enzyme replacement, pain control, or surgical interventions—may reduce the risk of recurrent DKA.

Additionally, patients should be aware that certain medications used in pancreatic disorders, such as octreotide for VIPomas or somatostatin analogs, can affect glucose metabolism. Any new symptom should be reported promptly.

Special Considerations: Pancreatic Surgery and DKA Risk

Patients who undergo total pancreatectomy (removal of the entire pancreas) become completely insulin-deficient and require lifelong insulin therapy. They are at high risk for DKA, especially if they miss insulin doses or develop intercurrent illness. Even after partial pancreatectomy, beta-cell mass may be insufficient to meet demand, particularly under stress. These patients should be managed with the same vigilance as type 1 diabetes. The NCBI Bookshelf chapter on pancreatectomy and diabetes provides further details on management.

Case Example: When DKA Mimics Pancreatitis

A 45-year-old man with a history of chronic pancreatitis due to alcohol use presented to the emergency department with severe epigastric pain, nausea, and vomiting for two days. He had no known diabetes. Initial labs showed glucose 180 mg/dL, lipase 120 U/L (mildly elevated), and serum bicarbonate 18 mEq/L. The team initially treated for pancreatitis. However, urine ketones were 3+, and arterial pH was 7.28. Beta-hydroxybutyrate was 4.2 mmol/L. The patient was diagnosed with euglycemic DKA and treated with intravenous fluids, insulin drip, and electrolyte replacement. His symptoms improved within 12 hours. This case illustrates how DKA can masquerade as a pancreatitis exacerbation and why ketone testing should be routine in high-risk patients.

External Resources and Further Reading

For clinicians and patients seeking more in-depth information, the following resources are authoritative:

Conclusion

Diabetic ketoacidosis in non-diabetic individuals with pancreatic disorders is an underrecognized emergency that requires a high index of suspicion. Symptoms such as hyperglycemia, nausea, abdominal pain, Kussmaul respirations, confusion, and fruity breath must not be dismissed, even in patients without a diabetes history. Prompt testing of blood glucose and ketones, along with arterial blood gas, can confirm the diagnosis. Prevention involves regular monitoring, patient education, and close collaboration between gastroenterologists, endocrinologists, and primary care providers. By raising awareness among both healthcare professionals and patients, the morbidity and mortality from DKA can be significantly reduced. If you or a loved one has a pancreatic disorder and develops any of the described symptoms, seek emergency medical care immediately—time is of the essence.